Investigating the effect of lavender on depression in patients with multiple sclerosis
Phase 3
Recruiting
- Conditions
- Multiple Sclerosis.
- Registration Number
- IRCT20190726044339N4
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Men and women with Relapsing-remitting multiple sclerosis patients with aged between ??-?? years
Score above ?? according to Persian- version of the Beck Depression Inventory-II (BDI-II-Persian)
Exclusion Criteria
Pregnancy and breastfeeding
Allergy to lavender
Unstable heart, kidney and liver patients
Seizures
Hypothyroidism
Consumption of alcohol or drugs
Patients who do not follow the study completely
Patients with severe depression
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Beck questionnaire score. Timepoint: Measurement of depression severity at the beginning of the study (before the start of the intervention) and 4, 8 weeks after the start of taking the drug or placebo. Method of measurement: Depression Beck questionnaire.
- Secondary Outcome Measures
Name Time Method